Advertisement

Index by author

February 01, 1993; Volume 264,Issue 2

A

  1. Adler, M W

    1. Cytokine reversal of morphine-induced suppression of the antibody response.
      J L Bussiere, M W Adler, T J Rogers and T K Eisenstein
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 591-597;

  2. Amoroso, S

    1. Inhibition of the Na(+)-Ca++ exchanger enhances anoxia and glucopenia-induced [3H]aspartate release in hippocampal slices.
      S Amoroso, S Sensi, G di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 515-520;

  3. Annunziato, L

    1. Inhibition of the Na(+)-Ca++ exchanger enhances anoxia and glucopenia-induced [3H]aspartate release in hippocampal slices.
      S Amoroso, S Sensi, G di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 515-520;

  4. Arneklo-Nobin, B

    1. Endothelial relaxing 5-hydroxytryptamine receptors in the rat jugular vein: similarity with the 5-hydroxytryptamine1C receptor.
      M Bodelsson, K Törnebrandt and B Arneklo-Nobin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 709-716;

B

  1. Bacci, E

    1. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
      G H Caughey, W W Raymond, E Bacci, R J Lombardy and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 676-682;

  2. Badger, T M

    1. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions.
      T M Badger, J Crouch, D Irby, R Hakkak and M Shahare
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 938-943;
    2. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

  3. Balster, R L

    1. Inhaled 1,1,1-trichloroethane-produced physical dependence in mice: effects of drugs and vapors on withdrawal.
      E B Evans and R L Balster
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 726-733;
    2. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
      D J Bobelis and R L Balster
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 845-853;

  4. Barnette, M S

    1. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
      M S Barnette, C D Manning, W J Price and F C Barone
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 801-812;

  5. Baron, S P

    1. Dipsogenic effects of excitatory amino acid agonists in pigeons.
      S P Baron and J H Woods
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 918-921;

  6. Barone, F C

    1. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
      M S Barnette, C D Manning, W J Price and F C Barone
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 801-812;

  7. Basbaum, A I

    1. Adrenal medullary modulation of the inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine.
      F J Miao, M F Dallman, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 839-844;

  8. Bass, P

    1. Effect of epidermal growth factor on experimental colitis in the rat.
      M S Luck and P Bass
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 984-990;

  9. Batt, A M

    1. Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.
      L Ferrari, J Y Jouzeau, P Gillet, R Herber, P Fener, A M Batt and P Netter
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1012-1020;

  10. Bealer, S L

    1. Histamine releases norepinephrine in the paraventricular nucleus/anterior hypothalamus of the conscious rat.
      S L Bealer
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 734-738;

  11. Ben-Ari, Y

    1. Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brain.
      S Zini, R Zini and Y Ben-Ari
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 701-708;

  12. Bengtsson, H I

    1. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
      S Lundin, A Broeders, M Ohlin, K Hansson, H I Bengtsson, J Trojnar and P Melin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 783-788;

  13. Benowitz, N L

    1. Adrenal medullary modulation of the inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine.
      F J Miao, M F Dallman, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 839-844;

  14. Bickford, P C

    1. The effects of ethanol on gamma-aminobutyric acid-induced depressions of cerebellar Purkinje neurons: influence of beta adrenergic receptor action in young and aged Fischer 344 rats.
      A M Lin, P C Bickford and M R Palmer
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 951-957;

  15. Bigelow, G E

    1. Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.
      K L Preston and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 813-823;

  16. Bobelis, D J

    1. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
      D J Bobelis and R L Balster
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 845-853;

  17. Bodelsson, M

    1. Endothelial relaxing 5-hydroxytryptamine receptors in the rat jugular vein: similarity with the 5-hydroxytryptamine1C receptor.
      M Bodelsson, K Törnebrandt and B Arneklo-Nobin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 709-716;

  18. Boundy, V A

    1. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.
      V A Boundy, R R Luedtke, A L Gallitano, J E Smith, T M Filtz, R G Kallen and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1002-1011;

  19. Bowen, W D

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

  20. Brechue, W F

    1. Carbonic anhydrase inhibitory activity and ocular pharmacology of organic sulfamates.
      W F Brechue and T H Maren
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 670-675;

  21. Breuer, A

    1. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
      T U Järbe, A J Hiltunen, D A Mathis, L Hanŭs, A Breuer and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 561-569;

  22. Brewer, J A

    1. Testosterone modulation of N-acetylation in mouse kidney.
      T N Smolen, J A Brewer and W W Weber
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 854-858;

  23. Broeders, A

    1. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
      S Lundin, A Broeders, M Ohlin, K Hansson, H I Bengtsson, J Trojnar and P Melin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 783-788;

  24. Buckner, C K

    1. Pharmacologic modulation of the influence of the epithelium on immunologic- and nonimmunologic-induced histamine release and contraction in guinea pig superfused tracheal strips.
      C K Buckner, R I Fishleder, R Conklin, J A Will, O Doran and F M Graziano
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 717-725;

  25. Burns, L A

    1. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
      L A Burns, L F Butterworth and A E Munson
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 695-700;

  26. Bussiere, J L

    1. Cytokine reversal of morphine-induced suppression of the antibody response.
      J L Bussiere, M W Adler, T J Rogers and T K Eisenstein
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 591-597;

  27. Butelman, E R

    1. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
      E R Butelman and J H Woods
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 762-769;

  28. Butterworth, L F

    1. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
      L A Burns, L F Butterworth and A E Munson
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 695-700;

C

  1. Carlisi, V J

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

  2. Caughey, G H

    1. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
      G H Caughey, W W Raymond, E Bacci, R J Lombardy and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 676-682;

  3. Chen, S G

    1. Inhibition of brain protein kinase C subtypes by lead.
      K Murakami, G Feng and S G Chen
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 757-761;

  4. Cheng, J B

    1. Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid.
      J B Cheng, J S Pillar, J T Shirley, H J Showell, J W Watson and V L Cohan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 922-929;

  5. Chinn, K

    1. Two delayed rectifiers in guinea pig ventricular myocytes distinguished by tail current kinetics.
      K Chinn
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 553-560;

  6. Chiodo, L A

    1. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
      D K Pitts, M D Kelland, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 616-621;

  7. Chowdhury, P

    1. Biochemical characterization of the effects of FK506 on signal transduction in exocytotic function of rat pancreatic acini.
      R Doi, K Inoue, P Chowdhury and P L Rayford
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 873-878;

  8. Clarke, D

    1. Alpha-2 adrenergic receptors in inner medullary collecting duct cells of the rabbit kidney.
      D Clarke and L C Garg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 879-888;

  9. Clarke, D E

    1. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
      M V Waikar, S S Hegde, A P Ford and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 654-661;

  10. Coffman, T M

    1. Characterization of glomerular thromboxane receptors in murine lupus nephritis.
      R F Spurney, J J Onorato, P Ruiz, D S Pisetsky and T M Coffman
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 584-590;

  11. Cohan, V L

    1. Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid.
      J B Cheng, J S Pillar, J T Shirley, H J Showell, J W Watson and V L Cohan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 922-929;

  12. Collins, A C

    1. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
      M J Marks, D A Farnham, S R Grady and A C Collins
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 542-552;

  13. Colpaert, F C

    1. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
      W Koek, F C Colpaert and J Vignon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 746-756;

  14. Conklin, R

    1. Pharmacologic modulation of the influence of the epithelium on immunologic- and nonimmunologic-induced histamine release and contraction in guinea pig superfused tracheal strips.
      C K Buckner, R I Fishleder, R Conklin, J A Will, O Doran and F M Graziano
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 717-725;

  15. Connell, T A

    1. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
      L W Zhou, S P Zhang, T A Connell and B Weiss
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 824-830;

  16. Cosentino, M

    1. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
      F de Ponti, A Einaudi, M Cosentino, L D'Angelo, S Lecchini, G M Frigo and A Crema
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 789-794;

  17. Crema, A

    1. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
      F de Ponti, A Einaudi, M Cosentino, L D'Angelo, S Lecchini, G M Frigo and A Crema
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 789-794;

  18. Cross, H S

    1. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro.
      K H Farsoudi, P Pietschmann, H S Cross and M Peterlik
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 579-583;

  19. Crouch, J

    1. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions.
      T M Badger, J Crouch, D Irby, R Hakkak and M Shahare
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 938-943;
    2. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

D

  1. D'Angelo, L

    1. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
      F de Ponti, A Einaudi, M Cosentino, L D'Angelo, S Lecchini, G M Frigo and A Crema
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 789-794;

  2. Dallman, M F

    1. Adrenal medullary modulation of the inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine.
      F J Miao, M F Dallman, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 839-844;

  3. de Ponti, F

    1. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
      F de Ponti, A Einaudi, M Cosentino, L D'Angelo, S Lecchini, G M Frigo and A Crema
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 789-794;

  4. DeSouza, E B

    1. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
      B Levant, D E Grigoriadis and E B DeSouza
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 991-1001;

  5. di Renzo, G

    1. Inhibition of the Na(+)-Ca++ exchanger enhances anoxia and glucopenia-induced [3H]aspartate release in hippocampal slices.
      S Amoroso, S Sensi, G di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 515-520;

  6. Doi, R

    1. Biochemical characterization of the effects of FK506 on signal transduction in exocytotic function of rat pancreatic acini.
      R Doi, K Inoue, P Chowdhury and P L Rayford
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 873-878;

  7. Doran, O

    1. Pharmacologic modulation of the influence of the epithelium on immunologic- and nonimmunologic-induced histamine release and contraction in guinea pig superfused tracheal strips.
      C K Buckner, R I Fishleder, R Conklin, J A Will, O Doran and F M Graziano
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 717-725;

  8. Dosaka-Akita, K

    1. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
      K Dosaka-Akita, F C Tortella, J W Holaday and J B Long
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 631-637;

  9. Drieze, J M

    1. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys.
      N K Mello, J B Kamien, S E Lukas, J H Mendelson, J M Drieze and J W Sholar
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 530-541;

E

  1. Einaudi, A

    1. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
      F de Ponti, A Einaudi, M Cosentino, L D'Angelo, S Lecchini, G M Frigo and A Crema
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 789-794;

  2. Eisenstein, T K

    1. Cytokine reversal of morphine-induced suppression of the antibody response.
      J L Bussiere, M W Adler, T J Rogers and T K Eisenstein
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 591-597;

  3. Emmett-Oglesby, M W

    1. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
      P L Prather, S M Rezazadeh, J D Lane, G A Rowan, M L Hooper, D A Lytle, M W Emmett-Oglesby and H Lal
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 622-630;

  4. Evans, E B

    1. Inhaled 1,1,1-trichloroethane-produced physical dependence in mice: effects of drugs and vapors on withdrawal.
      E B Evans and R L Balster
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 726-733;

F

  1. Fain, J N

    1. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
      J Sallés, M A Wallace and J N Fain
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 521-529;

  2. Farnham, D A

    1. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
      M J Marks, D A Farnham, S R Grady and A C Collins
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 542-552;

  3. Farsoudi, K H

    1. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro.
      K H Farsoudi, P Pietschmann, H S Cross and M Peterlik
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 579-583;

  4. Fattaccini, C M

    1. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
      E J Kidd, S Haj-Dahmane, T Jolas, L Lanfumey, C M Fattaccini, B Guardiola-Lemaitre, H Gozlan and M Hamon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 863-872;

  5. Fedan, J S

    1. Alteration in the modulatory role of respiratory epithelium after exposure of guinea pigs to respirable cotton dust.
      J A Smith, D G Frazer and J S Fedan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 683-688;

  6. Fener, P

    1. Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.
      L Ferrari, J Y Jouzeau, P Gillet, R Herber, P Fener, A M Batt and P Netter
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1012-1020;

  7. Feng, G

    1. Inhibition of brain protein kinase C subtypes by lead.
      K Murakami, G Feng and S G Chen
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 757-761;

  8. Ferrari, L

    1. Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.
      L Ferrari, J Y Jouzeau, P Gillet, R Herber, P Fener, A M Batt and P Netter
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1012-1020;

  9. Filtz, T M

    1. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.
      V A Boundy, R R Luedtke, A L Gallitano, J E Smith, T M Filtz, R G Kallen and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1002-1011;

  10. Fishleder, R I

    1. Pharmacologic modulation of the influence of the epithelium on immunologic- and nonimmunologic-induced histamine release and contraction in guinea pig superfused tracheal strips.
      C K Buckner, R I Fishleder, R Conklin, J A Will, O Doran and F M Graziano
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 717-725;

  11. Ford, A P

    1. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
      M V Waikar, S S Hegde, A P Ford and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 654-661;

  12. Forsberg, E J

    1. Effects of caffeine on cholinergic agonist- and K(+)-induced cytosolic Ca++ signals and secretion in porcine adrenal chromaffin cells.
      Y Xu and E J Forsberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 770-775;

  13. Frazer, D G

    1. Alteration in the modulatory role of respiratory epithelium after exposure of guinea pigs to respirable cotton dust.
      J A Smith, D G Frazer and J S Fedan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 683-688;

  14. Freeman, A S

    1. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
      D K Pitts, M D Kelland, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 616-621;

  15. Frigo, G M

    1. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
      F de Ponti, A Einaudi, M Cosentino, L D'Angelo, S Lecchini, G M Frigo and A Crema
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 789-794;

G

  1. Gallitano, A L

    1. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.
      V A Boundy, R R Luedtke, A L Gallitano, J E Smith, T M Filtz, R G Kallen and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1002-1011;

  2. Garg, L C

    1. Alpha-2 adrenergic receptors in inner medullary collecting duct cells of the rabbit kidney.
      D Clarke and L C Garg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 879-888;

  3. Gillet, P

    1. Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.
      L Ferrari, J Y Jouzeau, P Gillet, R Herber, P Fener, A M Batt and P Netter
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1012-1020;

  4. Glaum, S R

    1. Selective opioid agonists modulate afferent transmission in the rat nucleus tractus solitarius.
      H Rhim, S R Glaum and R J Miller
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 795-800;

  5. Gozlan, H

    1. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
      E J Kidd, S Haj-Dahmane, T Jolas, L Lanfumey, C M Fattaccini, B Guardiola-Lemaitre, H Gozlan and M Hamon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 863-872;

  6. Grady, S R

    1. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
      M J Marks, D A Farnham, S R Grady and A C Collins
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 542-552;

  7. Graziano, F M

    1. Pharmacologic modulation of the influence of the epithelium on immunologic- and nonimmunologic-induced histamine release and contraction in guinea pig superfused tracheal strips.
      C K Buckner, R I Fishleder, R Conklin, J A Will, O Doran and F M Graziano
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 717-725;

  8. Grider, J R

    1. Coexistence of histamine H1 and H2 receptors coupled to distinct signal transduction pathways in isolated intestinal muscle cells.
      G Morini, J F Kuemmerle, M Impicciatore, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 598-603;

  9. Grigoriadis, D E

    1. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
      B Levant, D E Grigoriadis and E B DeSouza
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 991-1001;

  10. Guardiola-Lemaitre, B

    1. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
      E J Kidd, S Haj-Dahmane, T Jolas, L Lanfumey, C M Fattaccini, B Guardiola-Lemaitre, H Gozlan and M Hamon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 863-872;

  11. Gummelt, D

    1. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
      M M Tropea, D Gummelt, M S Herzig and L M Leeb-Lundberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 930-937;

H

  1. Haj-Dahmane, S

    1. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
      E J Kidd, S Haj-Dahmane, T Jolas, L Lanfumey, C M Fattaccini, B Guardiola-Lemaitre, H Gozlan and M Hamon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 863-872;

  2. Hakkak, R

    1. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions.
      T M Badger, J Crouch, D Irby, R Hakkak and M Shahare
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 938-943;

  3. Halaris, A E

    1. Characterization of subtypes of alpha-2 adrenoceptors in the human brain.
      G A Ordway, S M Jaconetta and A E Halaris
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 967-976;

  4. Hamon, M

    1. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
      E J Kidd, S Haj-Dahmane, T Jolas, L Lanfumey, C M Fattaccini, B Guardiola-Lemaitre, H Gozlan and M Hamon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 863-872;

  5. Hansson, K

    1. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
      S Lundin, A Broeders, M Ohlin, K Hansson, H I Bengtsson, J Trojnar and P Melin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 783-788;

  6. Hanŭs, L

    1. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
      T U Järbe, A J Hiltunen, D A Mathis, L Hanŭs, A Breuer and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 561-569;

  7. Harris, D N

    1. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
      M L Ogletree, D N Harris, W A Schumacher, M L Webb and R N Misra
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 570-578;

  8. Hegde, S S

    1. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
      M V Waikar, S S Hegde, A P Ford and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 654-661;

  9. Herber, R

    1. Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.
      L Ferrari, J Y Jouzeau, P Gillet, R Herber, P Fener, A M Batt and P Netter
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1012-1020;

  10. Herzig, M S

    1. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
      M M Tropea, D Gummelt, M S Herzig and L M Leeb-Lundberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 930-937;

  11. Hiltunen, A J

    1. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
      T U Järbe, A J Hiltunen, D A Mathis, L Hanŭs, A Breuer and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 561-569;

  12. Hoffman, A

    1. Kinetics of drug action in disease states. XLI. Effect of adrenalectomy on the hypnotic activity of phenobarbital, the neurotoxicity of theophylline and pain sensitivity in rats.
      A Hoffman and G Levy
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 859-862;

  13. Holaday, J W

    1. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
      K Dosaka-Akita, F C Tortella, J W Holaday and J B Long
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 631-637;

  14. Hollenberg, M D

    1. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors.
      S G Yang, M Saifeddine, A Laniyonu and M D Hollenberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 958-966;

  15. Hooper, M L

    1. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
      P L Prather, S M Rezazadeh, J D Lane, G A Rowan, M L Hooper, D A Lytle, M W Emmett-Oglesby and H Lal
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 622-630;

  16. Howell, R E

    1. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
      R E Howell, B D Sickels and S L Woeppel
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 609-615;

  17. Hruby, V J

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

  18. Huang, H Y

    1. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
      R Jackisch, H Y Huang, W Reimann and N Limberger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 889-898;

  19. Huang, J

    1. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

I

  1. Impicciatore, M

    1. Coexistence of histamine H1 and H2 receptors coupled to distinct signal transduction pathways in isolated intestinal muscle cells.
      G Morini, J F Kuemmerle, M Impicciatore, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 598-603;

  2. Imura, N

    1. Tubular secretion and reabsorption of mercury compounds in mouse kidney.
      T Tanaka-Kagawa, A Naganuma and N Imura
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 776-782;

  3. Ingelman-Sundberg, M

    1. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

  4. Inoue, K

    1. Biochemical characterization of the effects of FK506 on signal transduction in exocytotic function of rat pancreatic acini.
      R Doi, K Inoue, P Chowdhury and P L Rayford
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 873-878;

  5. Irby, D

    1. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions.
      T M Badger, J Crouch, D Irby, R Hakkak and M Shahare
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 938-943;
    2. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

J

  1. Jackisch, R

    1. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
      R Jackisch, H Y Huang, W Reimann and N Limberger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 889-898;

  2. Jaconetta, S M

    1. Characterization of subtypes of alpha-2 adrenoceptors in the human brain.
      G A Ordway, S M Jaconetta and A E Halaris
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 967-976;

  3. Järbe, T U

    1. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
      T U Järbe, A J Hiltunen, D A Mathis, L Hanŭs, A Breuer and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 561-569;

  4. Johnston, P A

    1. A micropuncture study on the renal site of action of ICI 206,970, a unique eukalemic diuretic.
      P A Johnston and S T Kau
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 604-608;

  5. Jolas, T

    1. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
      E J Kidd, S Haj-Dahmane, T Jolas, L Lanfumey, C M Fattaccini, B Guardiola-Lemaitre, H Gozlan and M Hamon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 863-872;

  6. Jouzeau, J Y

    1. Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.
      L Ferrari, J Y Jouzeau, P Gillet, R Herber, P Fener, A M Batt and P Netter
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1012-1020;

K

  1. Kallen, R G

    1. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.
      V A Boundy, R R Luedtke, A L Gallitano, J E Smith, T M Filtz, R G Kallen and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1002-1011;

  2. Kamien, J B

    1. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys.
      N K Mello, J B Kamien, S E Lukas, J H Mendelson, J M Drieze and J W Sholar
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 530-541;

  3. Kau, S T

    1. A micropuncture study on the renal site of action of ICI 206,970, a unique eukalemic diuretic.
      P A Johnston and S T Kau
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 604-608;

  4. Kelland, M D

    1. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
      D K Pitts, M D Kelland, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 616-621;

  5. Kidd, E J

    1. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
      E J Kidd, S Haj-Dahmane, T Jolas, L Lanfumey, C M Fattaccini, B Guardiola-Lemaitre, H Gozlan and M Hamon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 863-872;

  6. Koek, W

    1. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
      W Koek, F C Colpaert and J Vignon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 746-756;

  7. Koob, G F

    1. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
      S S Negus, G W Pasternak, G F Koob and M B Weinger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 739-745;

  8. Kuemmerle, J F

    1. Coexistence of histamine H1 and H2 receptors coupled to distinct signal transduction pathways in isolated intestinal muscle cells.
      G Morini, J F Kuemmerle, M Impicciatore, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 598-603;

L

  1. Lal, H

    1. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
      P L Prather, S M Rezazadeh, J D Lane, G A Rowan, M L Hooper, D A Lytle, M W Emmett-Oglesby and H Lal
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 622-630;

  2. Lane, J D

    1. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
      P L Prather, S M Rezazadeh, J D Lane, G A Rowan, M L Hooper, D A Lytle, M W Emmett-Oglesby and H Lal
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 622-630;

  3. Lane, W V

    1. Nereistoxin: a naturally occurring toxin with redox effects on neuronal nicotinic acetylcholine receptors in chick retina.
      Y Xie, W V Lane and R H Loring
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 689-694;

  4. Lanfumey, L

    1. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
      E J Kidd, S Haj-Dahmane, T Jolas, L Lanfumey, C M Fattaccini, B Guardiola-Lemaitre, H Gozlan and M Hamon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 863-872;

  5. Laniyonu, A

    1. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors.
      S G Yang, M Saifeddine, A Laniyonu and M D Hollenberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 958-966;

  6. Lecchini, S

    1. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
      F de Ponti, A Einaudi, M Cosentino, L D'Angelo, S Lecchini, G M Frigo and A Crema
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 789-794;

  7. Leeb-Lundberg, L M

    1. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
      M M Tropea, D Gummelt, M S Herzig and L M Leeb-Lundberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 930-937;

  8. Levant, B

    1. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
      B Levant, D E Grigoriadis and E B DeSouza
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 991-1001;

  9. Levine, J D

    1. Adrenal medullary modulation of the inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine.
      F J Miao, M F Dallman, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 839-844;

  10. Levy, G

    1. Kinetics of drug action in disease states. XLI. Effect of adrenalectomy on the hypnotic activity of phenobarbital, the neurotoxicity of theophylline and pain sensitivity in rats.
      A Hoffman and G Levy
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 859-862;

  11. Liljequist, S

    1. Bicuculline-produced regional differences in the modulation of 35S-TBPS binding by GABA, pentobarbital and diazepam in mouse cerebellum and cortex.
      S Liljequist and B Tabakoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 638-647;

  12. Limberger, N

    1. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
      R Jackisch, H Y Huang, W Reimann and N Limberger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 889-898;

  13. Lin, A M

    1. The effects of ethanol on gamma-aminobutyric acid-induced depressions of cerebellar Purkinje neurons: influence of beta adrenergic receptor action in young and aged Fischer 344 rats.
      A M Lin, P C Bickford and M R Palmer
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 951-957;

  14. Lombardy, R J

    1. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
      G H Caughey, W W Raymond, E Bacci, R J Lombardy and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 676-682;

  15. Long, J B

    1. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
      K Dosaka-Akita, F C Tortella, J W Holaday and J B Long
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 631-637;

  16. Loring, R H

    1. Nereistoxin: a naturally occurring toxin with redox effects on neuronal nicotinic acetylcholine receptors in chick retina.
      Y Xie, W V Lane and R H Loring
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 689-694;

  17. Luck, M S

    1. Effect of epidermal growth factor on experimental colitis in the rat.
      M S Luck and P Bass
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 984-990;

  18. Luedtke, R R

    1. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.
      V A Boundy, R R Luedtke, A L Gallitano, J E Smith, T M Filtz, R G Kallen and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1002-1011;

  19. Lukas, S E

    1. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys.
      N K Mello, J B Kamien, S E Lukas, J H Mendelson, J M Drieze and J W Sholar
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 530-541;

  20. Lumpkin, C K

    1. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

  21. Lundin, S

    1. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
      S Lundin, A Broeders, M Ohlin, K Hansson, H I Bengtsson, J Trojnar and P Melin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 783-788;

  22. Lytle, D A

    1. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
      P L Prather, S M Rezazadeh, J D Lane, G A Rowan, M L Hooper, D A Lytle, M W Emmett-Oglesby and H Lal
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 622-630;

M

  1. Maixner, W

    1. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
      H Suarez-Roca and W Maixner
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 648-653;

  2. Makhlouf, G M

    1. Coexistence of histamine H1 and H2 receptors coupled to distinct signal transduction pathways in isolated intestinal muscle cells.
      G Morini, J F Kuemmerle, M Impicciatore, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 598-603;

  3. Manning, C D

    1. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
      M S Barnette, C D Manning, W J Price and F C Barone
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 801-812;

  4. Maren, T H

    1. Carbonic anhydrase inhibitory activity and ocular pharmacology of organic sulfamates.
      W F Brechue and T H Maren
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 670-675;

  5. Marks, M J

    1. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
      M J Marks, D A Farnham, S R Grady and A C Collins
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 542-552;

  6. Mathis, D A

    1. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
      T U Järbe, A J Hiltunen, D A Mathis, L Hanŭs, A Breuer and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 561-569;

  7. Mechoulam, R

    1. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
      T U Järbe, A J Hiltunen, D A Mathis, L Hanŭs, A Breuer and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 561-569;

  8. Mehvar, R

    1. Pharmacokinetics of 70-kilodalton fluorescein-dextran in experimental diabetes mellitus.
      R Mehvar and J M Reynolds
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 662-669;

  9. Melin, P

    1. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
      S Lundin, A Broeders, M Ohlin, K Hansson, H I Bengtsson, J Trojnar and P Melin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 783-788;

  10. Mello, N K

    1. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys.
      N K Mello, J B Kamien, S E Lukas, J H Mendelson, J M Drieze and J W Sholar
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 530-541;

  11. Mendelson, J H

    1. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys.
      N K Mello, J B Kamien, S E Lukas, J H Mendelson, J M Drieze and J W Sholar
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 530-541;

  12. Mercado, C

    1. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

  13. Miao, F J

    1. Adrenal medullary modulation of the inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine.
      F J Miao, M F Dallman, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 839-844;

  14. Miller, R J

    1. Selective opioid agonists modulate afferent transmission in the rat nucleus tractus solitarius.
      H Rhim, S R Glaum and R J Miller
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 795-800;

  15. Misra, R N

    1. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
      M L Ogletree, D N Harris, W A Schumacher, M L Webb and R N Misra
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 570-578;

  16. Molinoff, P B

    1. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.
      V A Boundy, R R Luedtke, A L Gallitano, J E Smith, T M Filtz, R G Kallen and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1002-1011;

  17. Morini, G

    1. Coexistence of histamine H1 and H2 receptors coupled to distinct signal transduction pathways in isolated intestinal muscle cells.
      G Morini, J F Kuemmerle, M Impicciatore, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 598-603;

  18. Mosberg, H I

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

  19. Munson, A E

    1. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
      L A Burns, L F Butterworth and A E Munson
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 695-700;

  20. Murakami, K

    1. Inhibition of brain protein kinase C subtypes by lead.
      K Murakami, G Feng and S G Chen
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 757-761;

N

  1. Naganuma, A

    1. Tubular secretion and reabsorption of mercury compounds in mouse kidney.
      T Tanaka-Kagawa, A Naganuma and N Imura
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 776-782;

  2. Negus, S S

    1. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
      S S Negus, G W Pasternak, G F Koob and M B Weinger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 739-745;

  3. Netter, P

    1. Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.
      L Ferrari, J Y Jouzeau, P Gillet, R Herber, P Fener, A M Batt and P Netter
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1012-1020;

O

  1. Ogletree, M L

    1. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
      M L Ogletree, D N Harris, W A Schumacher, M L Webb and R N Misra
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 570-578;

  2. Ohlin, M

    1. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
      S Lundin, A Broeders, M Ohlin, K Hansson, H I Bengtsson, J Trojnar and P Melin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 783-788;

  3. Onorato, J J

    1. Characterization of glomerular thromboxane receptors in murine lupus nephritis.
      R F Spurney, J J Onorato, P Ruiz, D S Pisetsky and T M Coffman
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 584-590;

  4. Ordway, G A

    1. Characterization of subtypes of alpha-2 adrenoceptors in the human brain.
      G A Ordway, S M Jaconetta and A E Halaris
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 967-976;

P

  1. Palmer, M R

    1. The effects of ethanol on gamma-aminobutyric acid-induced depressions of cerebellar Purkinje neurons: influence of beta adrenergic receptor action in young and aged Fischer 344 rats.
      A M Lin, P C Bickford and M R Palmer
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 951-957;

  2. Pasternak, G W

    1. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
      S S Negus, G W Pasternak, G F Koob and M B Weinger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 739-745;

  3. Peterlik, M

    1. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro.
      K H Farsoudi, P Pietschmann, H S Cross and M Peterlik
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 579-583;

  4. Pietschmann, P

    1. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro.
      K H Farsoudi, P Pietschmann, H S Cross and M Peterlik
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 579-583;

  5. Pillar, J S

    1. Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid.
      J B Cheng, J S Pillar, J T Shirley, H J Showell, J W Watson and V L Cohan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 922-929;

  6. Pisetsky, D S

    1. Characterization of glomerular thromboxane receptors in murine lupus nephritis.
      R F Spurney, J J Onorato, P Ruiz, D S Pisetsky and T M Coffman
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 584-590;

  7. Pitts, D K

    1. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
      D K Pitts, M D Kelland, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 616-621;

  8. Porreca, F

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

  9. Portoghese, P S

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

  10. Prather, P L

    1. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
      P L Prather, S M Rezazadeh, J D Lane, G A Rowan, M L Hooper, D A Lytle, M W Emmett-Oglesby and H Lal
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 622-630;

  11. Preston, K L

    1. Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.
      K L Preston and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 813-823;

  12. Price, W J

    1. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
      M S Barnette, C D Manning, W J Price and F C Barone
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 801-812;

R

  1. Rabin, R A

    1. Ethanol-induced desensitization of adenylate cyclase: role of the adenosine receptor and GTP-binding proteins.
      R A Rabin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 977-983;

  2. Rayford, P L

    1. Biochemical characterization of the effects of FK506 on signal transduction in exocytotic function of rat pancreatic acini.
      R Doi, K Inoue, P Chowdhury and P L Rayford
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 873-878;

  3. Raymond, W W

    1. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
      G H Caughey, W W Raymond, E Bacci, R J Lombardy and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 676-682;

  4. Reimann, W

    1. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
      R Jackisch, H Y Huang, W Reimann and N Limberger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 889-898;

  5. Reynolds, J M

    1. Pharmacokinetics of 70-kilodalton fluorescein-dextran in experimental diabetes mellitus.
      R Mehvar and J M Reynolds
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 662-669;

  6. Rezazadeh, S M

    1. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
      P L Prather, S M Rezazadeh, J D Lane, G A Rowan, M L Hooper, D A Lytle, M W Emmett-Oglesby and H Lal
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 622-630;

  7. Rhim, H

    1. Selective opioid agonists modulate afferent transmission in the rat nucleus tractus solitarius.
      H Rhim, S R Glaum and R J Miller
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 795-800;

  8. Rogers, T J

    1. Cytokine reversal of morphine-induced suppression of the antibody response.
      J L Bussiere, M W Adler, T J Rogers and T K Eisenstein
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 591-597;

  9. Ronis, M J

    1. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

  10. Rowan, G A

    1. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
      P L Prather, S M Rezazadeh, J D Lane, G A Rowan, M L Hooper, D A Lytle, M W Emmett-Oglesby and H Lal
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 622-630;

  11. Ruiz, P

    1. Characterization of glomerular thromboxane receptors in murine lupus nephritis.
      R F Spurney, J J Onorato, P Ruiz, D S Pisetsky and T M Coffman
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 584-590;

S

  1. Saifeddine, M

    1. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors.
      S G Yang, M Saifeddine, A Laniyonu and M D Hollenberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 958-966;

  2. Sallés, J

    1. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
      J Sallés, M A Wallace and J N Fain
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 521-529;

  3. Sawchuk, R J

    1. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis.
      S L Wong, K Van Belle and R J Sawchuk
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 899-909;

  4. Schumacher, W A

    1. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
      M L Ogletree, D N Harris, W A Schumacher, M L Webb and R N Misra
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 570-578;

  5. Sensi, S

    1. Inhibition of the Na(+)-Ca++ exchanger enhances anoxia and glucopenia-induced [3H]aspartate release in hippocampal slices.
      S Amoroso, S Sensi, G di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 515-520;

  6. Shahare, M

    1. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions.
      T M Badger, J Crouch, D Irby, R Hakkak and M Shahare
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 938-943;

  7. Shirley, J T

    1. Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid.
      J B Cheng, J S Pillar, J T Shirley, H J Showell, J W Watson and V L Cohan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 922-929;

  8. Sholar, J W

    1. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys.
      N K Mello, J B Kamien, S E Lukas, J H Mendelson, J M Drieze and J W Sholar
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 530-541;

  9. Showell, H J

    1. Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid.
      J B Cheng, J S Pillar, J T Shirley, H J Showell, J W Watson and V L Cohan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 922-929;

  10. Sickels, B D

    1. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
      R E Howell, B D Sickels and S L Woeppel
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 609-615;

  11. Smith, J A

    1. Alteration in the modulatory role of respiratory epithelium after exposure of guinea pigs to respirable cotton dust.
      J A Smith, D G Frazer and J S Fedan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 683-688;

  12. Smith, J E

    1. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.
      V A Boundy, R R Luedtke, A L Gallitano, J E Smith, T M Filtz, R G Kallen and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 1002-1011;

  13. Smolen, T N

    1. Testosterone modulation of N-acetylation in mouse kidney.
      T N Smolen, J A Brewer and W W Weber
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 854-858;

  14. Spurney, R F

    1. Characterization of glomerular thromboxane receptors in murine lupus nephritis.
      R F Spurney, J J Onorato, P Ruiz, D S Pisetsky and T M Coffman
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 584-590;

  15. Suarez-Roca, H

    1. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
      H Suarez-Roca and W Maixner
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 648-653;

  16. Sultana, M

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

T

  1. Tabakoff, B

    1. Bicuculline-produced regional differences in the modulation of 35S-TBPS binding by GABA, pentobarbital and diazepam in mouse cerebellum and cortex.
      S Liljequist and B Tabakoff
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 638-647;

  2. Takemori, A E

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

  3. Tanaka-Kagawa, T

    1. Tubular secretion and reabsorption of mercury compounds in mouse kidney.
      T Tanaka-Kagawa, A Naganuma and N Imura
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 776-782;

  4. Tidwell, R R

    1. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
      G H Caughey, W W Raymond, E Bacci, R J Lombardy and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 676-682;

  5. Törnebrandt, K

    1. Endothelial relaxing 5-hydroxytryptamine receptors in the rat jugular vein: similarity with the 5-hydroxytryptamine1C receptor.
      M Bodelsson, K Törnebrandt and B Arneklo-Nobin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 709-716;

  6. Tortella, F C

    1. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
      K Dosaka-Akita, F C Tortella, J W Holaday and J B Long
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 631-637;

  7. Trojnar, J

    1. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
      S Lundin, A Broeders, M Ohlin, K Hansson, H I Bengtsson, J Trojnar and P Melin
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 783-788;

  8. Tropea, M M

    1. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
      M M Tropea, D Gummelt, M S Herzig and L M Leeb-Lundberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 930-937;

V

  1. Valentine, C R

    1. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats.
      M J Ronis, J Huang, J Crouch, C Mercado, D Irby, C R Valentine, C K Lumpkin, M Ingelman-Sundberg and T M Badger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 944-950;

  2. Van Belle, K

    1. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis.
      S L Wong, K Van Belle and R J Sawchuk
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 899-909;

  3. Vickroy, T W

    1. Presynaptic cholinergic actions by the putative cognitive enhancing agent DuP 996.
      T W Vickroy
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 910-917;

  4. Vignon, J

    1. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
      W Koek, F C Colpaert and J Vignon
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 746-756;

W

  1. Waikar, M V

    1. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
      M V Waikar, S S Hegde, A P Ford and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 654-661;

  2. Wallace, M A

    1. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
      J Sallés, M A Wallace and J N Fain
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 521-529;

  3. Watson, J W

    1. Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid.
      J B Cheng, J S Pillar, J T Shirley, H J Showell, J W Watson and V L Cohan
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 922-929;

  4. Webb, M L

    1. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
      M L Ogletree, D N Harris, W A Schumacher, M L Webb and R N Misra
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 570-578;

  5. Weber, W W

    1. Testosterone modulation of N-acetylation in mouse kidney.
      T N Smolen, J A Brewer and W W Weber
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 854-858;

  6. Weinger, M B

    1. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
      S S Negus, G W Pasternak, G F Koob and M B Weinger
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 739-745;

  7. Weiss, B

    1. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
      L W Zhou, S P Zhang, T A Connell and B Weiss
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 824-830;

  8. Wild, K D

    1. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
      K D Wild, V J Carlisi, H I Mosberg, W D Bowen, P S Portoghese, M Sultana, A E Takemori, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 831-838;

  9. Will, J A

    1. Pharmacologic modulation of the influence of the epithelium on immunologic- and nonimmunologic-induced histamine release and contraction in guinea pig superfused tracheal strips.
      C K Buckner, R I Fishleder, R Conklin, J A Will, O Doran and F M Graziano
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 717-725;

  10. Woeppel, S L

    1. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
      R E Howell, B D Sickels and S L Woeppel
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 609-615;

  11. Wong, S L

    1. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis.
      S L Wong, K Van Belle and R J Sawchuk
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 899-909;

  12. Woods, J H

    1. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
      E R Butelman and J H Woods
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 762-769;
    2. Dipsogenic effects of excitatory amino acid agonists in pigeons.
      S P Baron and J H Woods
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 918-921;

X

  1. Xie, Y

    1. Nereistoxin: a naturally occurring toxin with redox effects on neuronal nicotinic acetylcholine receptors in chick retina.
      Y Xie, W V Lane and R H Loring
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 689-694;

  2. Xu, Y

    1. Effects of caffeine on cholinergic agonist- and K(+)-induced cytosolic Ca++ signals and secretion in porcine adrenal chromaffin cells.
      Y Xu and E J Forsberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 770-775;

Y

  1. Yang, S G

    1. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors.
      S G Yang, M Saifeddine, A Laniyonu and M D Hollenberg
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 958-966;

Z

  1. Zhang, S P

    1. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
      L W Zhou, S P Zhang, T A Connell and B Weiss
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 824-830;

  2. Zhou, L W

    1. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
      L W Zhou, S P Zhang, T A Connell and B Weiss
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 824-830;

  3. Zini, R

    1. Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brain.
      S Zini, R Zini and Y Ben-Ari
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 701-708;

  4. Zini, S

    1. Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brain.
      S Zini, R Zini and Y Ben-Ari
      Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 701-708;
Back to top

In this issue

Advertisement